Comparative Analysis of Salvage Partial Nephrectomy Versus Radical Nephrectomy after the Failure of Initial Partial Nephrectomy

Jiwei Huang,Ruopeng Su,Cuijian Zhang,Yige Bao,Xiaoyi Hu,Xiongjun Ye,Minfeng Chen,Ping Wang,Jitao Wu,Yueming Wang,Qi Tang,Zhiyang Huang,Bing Zheng,Chancan Li,Jianming Guo,Yiran Huang,Qiang Wei,Zhisong He,Wei Xue
DOI: https://doi.org/10.1016/j.urolonc.2023.07.010
2023-01-01
Abstract:Objectives: To compare the oncologic outcomes and renal function discrepancy of salvage partial nephrectomy (sPN) and salvage radical nephrectomy (sRN) after an initial failed PN.Materials and Methods: Retrospective data from multiple centers between 2008 and 2022 were analyzed in this study. Patients who received sPN or sRN after an initial failed PN were identified. Comparative analysis and propensity score matching (PSM) was performed and the RENAL score, tumor size, and pathological T stage at salvage surgery were used to match the 2 groups. Local recurrence-free survival (LRFS) and recurrence-free survival (RFS) were assessed using the Cox proportional hazards model and log-rank tests. Renal function after salvage surgery was assessed using the Wilcoxon rank sum test.Results: A total of 140 patients who underwent salvage surgery were evaluated, of whom 60 were considered for PSM analysis after matching. At a median follow-up of 27.0 months, LRFS and RFS showed no significant difference between sPN and sRN, either before (LRFS, HR = 0.673 [95% CI: 0.171-2.644], P = 0.610; RFS, HR = 0.744 [95% CI: 0.271-1.344], P = 0.595) or after matching (LRFS, HR = 1.080 [95% CI: 0.067-17.30], P = 0.957; RFS, HR = 1.199 [95% CI: 0.241-5.983], P = 0.822). During long-term follow-up, sPN pre-served renal function (after matching, eGFR, 71.4 vs. 54.0, P < 0.001) and prevented eGFR loss (after matching: 6.6% vs. 25.6%, P < 0.001).Conclusion: Salvage partial nephrectomy offers a better alternative than sRN for recurrence after initial PN, as sPN preserves renal func-tion better while maintaining parallel tumor control and acceptable complication rates. (c) 2023 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?